Clinical Trial Update: Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imetelstat as maintenance therapy after induction chemotherapy in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: Geron Corporation | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED